B. Braun OEM Division - System-built Solutions. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

B. Braun OEM Division – System-built Solutions.

Expertise in contract manufacturing and infusion therapy products

B. Braun supplies healthcare markets worldwide and is employing approx. 48,000 individuals. Based on this expertise the B. Braun OEM Division serves the pharmaceutical and medical devices industry.

At B. Braun OEM we offer contract manufacturing for infusion, irrigation and volume replacement solutions as well as standard injectables, anesthetics and dermatological products like creams, gels and pomades. Depending on the product requirements, we can fill in containers of different sizes, shapes and materials.

Furthermore, we provide a wide range of infusion therapy products. We supply all that is needed to admixture and infuse or inject a drug. You can order standard products or a customized version.

Partnering with us provides you with complete outsourcing knowledge. Our project management teams are the experts for individual customer ideas.

We can handle manufacturing projects and will customize a product or set according to your detailed specifications.

Products:

  • Pharmaceutical Solutions
  • Medical Devices
  • Products for Disinfection and Hygiene

Project management services:

  • Customized Products (modified characteristics, private label etc.)
  • Customized Sets Pharmaceutical
  • Contract Manufacturing
  • Common Development

B. Braun Melsungen AG
Website: www.bbraunoem.com
E-mail: info-europe@bbraunoem.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
FindPharma Custom Search

Click here